Senior Director, Global Oncology RWD Platform

AstraZeneca•Gaithersburg, MD
•$229,047 - $343,570•Onsite

About The Position

AstraZeneca’s Evidence Generation to Publications (EG2P) team is building APOLLO (AZ Partnerships in Oncology Leveraging real world evidence), a global oncology real-world data (RWD) platform supporting oncology evidence generation. APOLLO brings together data partners across markets and tumor types to support insight discovery, medical strategy, and publication-grade evidence generation. Reporting to the Head, NextGen Sciences, the Senior Director will serve as the scientific lead for the platform’s future. The role will drive APOLLO’s expansion across geographies, tumor areas, and use cases; shape its partner strategy; and communicate the value of accessing RWD through APOLLO across the Oncology Business Unit (OBU). This office-based position requires less than 10% travel.

Requirements

  • Advanced degree (MSc, PharmD, PhD, or equivalent) in epidemiology, outcomes research, statistics, health economics, or a related field.
  • 10 or more years of experience in RWE or RWD in pharma, biotech, a data or analytics company, consulting, or academia, including building or governing RWD assets.
  • Deep expertise in real-world research methods, pharmacoepidemiology, and HEOR.
  • Judgment to define data structures and inclusion criteria for multiple use cases.
  • Oncology RWE experience across multiple tumor types.
  • Hands-on experience applying tools for curation and abstraction of unstructured EHR data.

Nice To Haves

  • PhD in a relevant discipline.
  • Track record of negotiating or managing external data partnerships.
  • Knowledge of current regulatory and HTA expectations for RWE.
  • Experience with dashboards or data visualization tools for non-technical users.
  • Demonstrated leadership and management experience, including effective problem and conflict resolution skills and a validated team focus.

Responsibilities

  • Own the APOLLO data strategy and roadmap, including future data sources, markets, tumor types, and evidence use cases.
  • Identify and assess potential data partners and sources, including their structure, completeness, provenance, and suitability for regulatory-grade or publication-grade use.
  • Conduct feasibility assessments to determine whether potential partners fit APOLLO’s strategy of expanding access to real-world oncology data.
  • Identify, evaluate, and negotiate with data partners worldwide, particularly in markets with limited oncology RWD.
  • Work with global RWD leaders to develop new data assets and address oncology RWD gaps.
  • Assess and pilot approaches to RWD collection and curation, including AI/NLP-enabled abstraction from unstructured EHR data, and establish validation standards.
  • Develop and implement strategies and a roadmap to support APOLLO’s continued growth and ensure timely, meaningful data availability for global oncology RWE needs.
  • Participate in Integrated Evidence Plan (IEP) development to identify opportunities for APOLLO utilization.
  • Shape and communicate APOLLO’s future and value to Oncology stakeholders, senior leaders, and external experts, including through guidance, dashboards, conferences, and publications.
  • Lead a matrix team across EG2P and the wider Oncology Business Unit, and mentor colleagues to develop RWE capabilities.
  • Foster collaborative relationships with external experts to shape future APOLLO initiatives.
  • Ensure Medical and business activities comply with AstraZeneca standards, standard operating procedures (SOPs), and external regulations.

Benefits

  • Eligibility for short-term incentive bonuses.
  • Equity-based awards for salaried roles.
  • Qualified retirement programs.
  • Paid time off, including vacation, holidays, and leaves.
  • Health coverage.
  • Dental coverage.
  • Vision coverage.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service